Increasingly affordable renewables, coupled with consumers’ sensitivity to environmental, social and governance (ESG) issues, are driving a profound shift in energy markets worldwide. Nowhere is this more apparent than in brand equity, and the trust levels displayed by the public
Advertising
Rebranding in the energy market – The issues to consider
A number of energy giants have recently undergone corporate rebranding exercises. The motivations of these powerhouses often vary, from unifying a group after a series of mergers and acquisitions, to repairing reputational damage, to just aligning with a new corporate…
Stay safe on social media – New ACCC guidelines
Businesses shelling out big bucks for prime advertising space are used to paying close attention to content, for the sake of the bottom line as well as out of respect for consumer law. However, it may not feel as natural…
Marketing class actions – A new frontier
Australia has a long history of class action litigation. Outside of the United States, Australia has one of the most active class action markets globally.
It is 25 years since the introduction of the class action regime in the Federal…
Web Advertising – Complying with FTC’s “Clear & Conspicuous” Rule
Increasingly, companies are turning to the internet and social media platforms to advertise their products, often by using native advertising or by providing incentives such as payments or free products to social media “influencers” (Instagrammers, Pinners, Bloggers and Vloggers, to…
Package as “Advertising”
On October 17, 2016, a US federal trial court in the District of Columbia ruled that a competitor may pursue a Lanham Act claim for false advertising due to a container of black pepper. Watkins Inc. v. McCormick & Co.…
Competition Bureau alleges Moose Knuckles’ “Made in Canada” claims are false and misleading
On April 26, 2016, Canada’s Competition Bureau filed an application with the Competition Tribunal alleging that Moose International Inc., carrying on business as Moose Knuckles, engaged in deceptive marketing practices and that the “Made in Canada” claims associated with…
Amarin and FDA settle off-label suit
As we reported last August, US District Judge Paul Engelmayer ruled that Amarin Pharma has a First Amendment right to truthfully promote its prescription drug Vascepa for off-label uses. August 10, 2015, article. Shortly afterward, Amarin and the government…